TrialThe Journal of allergy and clinical immunology2013

Omalizumab increases the intrinsic sensitivity of human basophils to IgE-mediated stimulation.

Donald W Macglashan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.